Across TCGA pan-cancer cohorts, GLRXP1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of GLRXP1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where GLRXP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GLRXP1 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

COAD and KICH are the cancer types where GLRXP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GLRXP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.169	.028	4	view →
KICH	All	All	−0.033	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: GLRXP1 RNA expression & survival · all GLRXP1 data types